Cancer

Browse and view ASGCT's cancer-focused content on-demand. This resource is made available exclusively for ASGCT members.

Not an ASGCT Member? Join Today!

ASGCT membership unlocks incredible discounts and on-demand access to a rich archive documenting the history of cell and gene therapy. Take the next step in your career by becoming an ASGCT member.

Find Cancer Content

"How to" with CAR T Cell Therapy

January 21, 2022
During this two-hour café, Dr. Stephen Gottschalk gives a short introduction about gene therapy and continues into a structured discussion about CAR T-cell therapy. 🔒

Friend or Foe? Innate Immune Responses and Non-Viral Gene Delivery

October 20, 2023
Discover the latest insights into how pathogen recognition and innate immune signaling affect non-viral nucleic acid delivery. 🔒

Molecular Therapy Presents: Targets and Biomarkers

April 23, 2024
This webinar dives into cutting-edge strategies in target discovery and biomarkers. 🔒

Novel CAR T-cell Therapies for Malignancies

October 5, 2024
Speakers during this session review the current state of CAR T-cell therapies. They also provide updates on how CRISPR-based genome editing technologies are being applied to further understanding of T-cell function and to create novel T-cell products for patients. 🔒

Spotlight on Immuno-Oncology: B-Cell Malignancies and Beyond

August 1, 2023
This program aims to transcend the basics of cell therapy and CAR T cells and digs deeper into gene engineering and the intersection of gene and cell therapy in this space. 🔒

Spotlight on Immuno-Oncology: Beyond T Cells

August 2, 2023
This program aims to transcend the basics of cell therapy and CAR T cells and digs deeper into gene engineering and the intersection of gene and cell therapy in this space. 🔒

Spotlight on Immuno-Oncology: Direct In Vivo Delivery

August 1, 2023
This program aims to transcend the basics of cell therapy and CAR T cells and digs deeper into gene engineering and the intersection of gene and cell therapy in this space. 🔒

Spotlight on Immuno-Oncology: Genome and Epigenome Editing for Cancer Immunotherapy

August 2, 2023
This program aims to transcend the basics of cell therapy and CAR T cells and digs deeper into gene engineering and the intersection of gene and cell therapy in this space. 🔒

Spotlight on Immuno-Oncology: Novel CAR Designs and Approaches

August 1, 2023
This program aims to transcend the basics of cell therapy and CAR T cells and digs deeper into gene engineering and the intersection of gene and cell therapy in this space. 🔒

Spotlight on Immuno-Oncology: TCR-Based Cancer Immunotherapy

August 1, 2023
This program aims to transcend the basics of cell therapy and CAR T cells and digs deeper into gene engineering and the intersection of gene and cell therapy in this space. 🔒

Tumor Infiltrating Lymphocytes and Tumor Specific Antigens

June 10, 2022
Dr. Cerullo discusses tumor-infiltrating lymphocytes (TILs), an experimental cell therapy being developed for treating solid tumors, and tumor-specific antigens (TSAs), which can help the body make an immune response against cancer cells. 🔒

2025

Class Considerations on Immunogenicity for AAV GT Products

January 22-23, 2025 | Virtual

This site uses cookies to offer you a better user experience and to analyze site traffic. By continuing to use this website, you accept our use of cookies.